相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Cox regression and survival analysis from the tauro-urso-deoxycholic trial in amyotrophic lateral sclerosis
Giorgio Reggiardo et al.
FRONTIERS IN NEUROLOGY (2023)
Analysis of sodium phenylbutyrate and taurursodiol survival effect in ALS using external controls
Sabrina Paganoni et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2023)
Effect of tauroursodeoxycholic acid on survival and safety in amyotrophic lateral sclerosis: a retrospective population-based cohort study
Elisabetta Zucchi et al.
ECLINICALMEDICINE (2023)
Effect of sodium phenylbutyrate/taurursodiol on tracheostomy/ventilation-free survival and hospitalisation in amyotrophic lateral sclerosis: long-term results from the CENTAUR trial
Sabrina Paganoni et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2022)
Review of disease-modifying drug trials in amyotrophic lateral sclerosis
Paolo Tornese et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2022)
Survival analyses from the CENTAUR trial in amyotrophic lateral sclerosis: Evaluating the impact of treatment crossover on outcomes
Sabrina Paganoni et al.
MUSCLE & NERVE (2022)
Tauroursodeoxycholic acid: a potential therapeutic tool in neurodegenerative diseases
Kareem Khalaf et al.
TRANSLATIONAL NEURODEGENERATION (2022)
Tauroursodeoxycholic acid in patients with amyotrophic lateral sclerosis: The TUDCA-ALS trial protocol
Alberto Albanese et al.
FRONTIERS IN NEUROLOGY (2022)
Long-term survival of participants in the CENTAUR trial of sodium phenylbutyrate-taurursodiol in amyotrophic lateral sclerosis
Sabrina Paganoni et al.
MUSCLE & NERVE (2021)
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
Matthew J. Page et al.
BMJ-BRITISH MEDICAL JOURNAL (2021)
Trial of Sodium Phenylbutyrate-Taurursodiol for Amyotrophic Lateral Sclerosis
Sabrina Paganoni et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
A Stem Cell-Based Screening Platform Identifies Compounds that Desensitize Motor Neurons to Endoplasmic Reticulum Stress
Sebastian Thams et al.
MOLECULAR THERAPY (2019)
Tauroursodeoxycholic acid in the treatment of patients with amyotrophic lateral sclerosis
A. E. Elia et al.
EUROPEAN JOURNAL OF NEUROLOGY (2016)
Reporting Discrepancies Between the ClinicalTrials.gov Results Database and Peer-Reviewed Publications
Daniel M. Hartung et al.
ANNALS OF INTERNAL MEDICINE (2014)
Post-hoc data analysis: benefits and limitations
Douglas Curran-Everett et al.
CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY (2013)
Oral Solubilized Ursodeoxycholic Acid Therapy in Amyotrophic Lateral Sclerosis: A Randomized Cross-Over Trial
Ju-Hong Min et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2012)
Phase 2 study of sodium phenylbutyrate in ALS
Merit E. Cudkowicz et al.
AMYOTROPHIC LATERAL SCLEROSIS (2009)